Nuclear protein interactions with the human KDR/flk-1 promoter in vivo - Regulation of Sp1 binding is associated with cell type-specific expression

被引:46
|
作者
Patterson, C [1 ]
Wu, YX [1 ]
Lee, ME [1 ]
DeVault, JD [1 ]
Runge, MS [1 ]
Haber, E [1 ]
机构
[1] HARVARD UNIV, SCH PUBL HLTH, CARDIOVASC BIOL LAB, BOSTON, MA 02115 USA
关键词
D O I
10.1074/jbc.272.13.8410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The endothelial cell type-specific tyrosine kinase KDR/flk-1 is a receptor for vascular endothelial growth factor and a critical regulator of endothelial cell growth and development. To study mechanisms of endothelial cell differentiation and gene regulation, we have analyzed the topology of the proximal promoter of human KDR/flk-1. A protected sequence between base pairs -110 and -25 was defined by in vitro DNase I footprinting analysis in human umbilical vein endothelial cells (HUVECs), Purified Sp1 alone produced similar protection, and electrophoretic mobility shift assays demonstrated that Sp1 was indeed the major nuclear protein binding to this region, Despite the cell type specificity of KDR/flk-1 expression, no cell type differences were observed in DNA-protein interactions in vitro, In contrast, in vivo footprinting assays demonstrated marked differences in core promoter interactions between cell types, Protection of Sp1 binding sites was observed in HUVECs by in vivo DNase I footprinting, whereas in human fibroblasts and HeLa cells a pattern consistent with nucleosomal positioning was observed. In vivo dimethylsulfate footprinting confirmed that DNA-protein interactions occurred within Sp1 elements in HUVECs but not in nonendothelial cells. It is possible that distant elements coordinate Sp1 binding and chromatin structure to regulate cell type-specific expression of KDR/flk-1.
引用
收藏
页码:8410 / 8416
页数:7
相关论文
共 50 条
  • [1] Shear stress induces expression of vascular endothelial growth factor receptor Flk-1/KDR through the CT-rich Sp1 binding site
    Abumiya, T
    Sasaguri, T
    Taba, Y
    Miwa, Y
    Miyagi, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (06) : 907 - 913
  • [2] Nuclear factor-κB and cAMP response element binding protein mediate opposite transcriptional effects on the Flk-1/KDR gene promoter
    Illi, B
    Puri, P
    Morgante, L
    Capogrossi, MC
    Gaetano, C
    CIRCULATION RESEARCH, 2000, 86 (12) : E110 - E121
  • [3] CELL TYPE-SPECIFIC PROTEIN-DNA INTERACTIONS IN THE HUMAN ZETA-GLOBIN UPSTREAM PROMOTER REGION - DISPLACEMENT OF SP1 BY THE ERYTHROID CELL-SPECIFIC FACTOR NF-E1
    YU, CY
    CHEN, J
    LIN, LI
    TAM, M
    SHEN, CKJ
    MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (01) : 282 - 294
  • [4] In vivo footprinting of the human 11β-hydroxysteroid dehydrogenase type 2 promoter -: Evidence for cell-specific regulation by Sp1 and Sp3
    Nawrocki, AR
    Goldring, CE
    Kostadinova, RM
    Frey, FJ
    Frey, BM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) : 14647 - 14656
  • [5] Regulation of the human endothelial cell protein C receptor gene promoter by multiple Sp1 binding sites
    Rance, JB
    Follows, GA
    Cockerill, PN
    Bonifer, C
    Lane, DA
    Simmonds, RE
    BLOOD, 2003, 101 (11) : 4393 - 4401
  • [6] Transcriptional regulation of cell-specific expression of the human cystathionine β-synthase gene by differential binding of Sp1/Sp3 to the-1b promoter
    Ge, YB
    Matherly, LH
    Taub, JW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) : 43570 - 43579
  • [7] Activator protein 1 activity is involved in the regulation of the cell type-specific expression from the proximal promoter of the human profilaggrin gene
    Jang, SI
    Steinert, PM
    Markova, NG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) : 24105 - 24114
  • [8] Activation of KDR/flk-1 promoter by endothelial PAS domain protein 1: Potential role of endothelial PAS domain protein 1 in endothelial cell differentiation
    Maemura, K
    Jain, MK
    Decarie, LA
    Liu, YX
    Kourembanas, S
    Milstone, DS
    Lee, SL
    Perrella, MA
    Yet, SF
    Lee, ME
    CIRCULATION, 1998, 98 (17) : 729 - 729
  • [9] A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model
    Zhang W.
    Ran S.
    Sambade M.
    Huang X.
    Thorpe P.E.
    Angiogenesis, 2002, 5 (1-2) : 35 - 44
  • [10] Role of CpG methylation and Sp1 on cell type-specific expression of aquaporin-5 gene
    Nomura, Johji
    Hisatsune, Akinori
    Miyata, Takeshi
    Isohama, Yoichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 118P - 118P